DEF 14A

Company

Marker Therapeutics, Inc.

Filed

July 12, 2017

Period of Report

August 29, 2017

Accession Number

0001144204-17-036528

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →